Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old

NCT03257241 is registered in ClinicalTrials.gov with Polish Adult Leukemia Group as lead sponsor.

NCT NCT03257241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03257241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old
Lead sponsor
Polish Adult Leukemia Group
Phase
Phase 3
Overall status
Unknown status
Start date
July 3, 2017
Completion date
December 31, 2022
Enrollment
582 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia